missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Description
El ADP afecta la activación de las plaquetas a través de su interacción con los receptores de ADP P2Y1, P2Y12 y P2X1. Al convertirse en adenosina por los ecto-ADPases, la activación de las plaquetas se inhibe a través de los receptores de adenosina.
Specifications
Specifications
| Cantidad | 500 mg |
| Rotación óptica | [α]20/D -29.6±1° c = 0.5% in 0.5M Na2HPO4 (Lit.) |
| Formula Weight (peso de la fórmula) | 471.2 |
| Porcentaje de pureza | ≥95% |
| Forma física | Polvo blanco |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?